All posts tagged "glaxosmithkline"
-
FDA approves HIV treatment replacing daily pills with monthly injections
Viiv Healthcare's Cabenuva replaces a traditional daily pill regimen with two injections every month
-
PrEP injection every two months proves more effective than daily Truvada
GlaxoSmithKline stopped clinical trials of the PrEP drug early due to its efficacy at preventing new HIV transmissions
-
Bimonthly injections as effective as pills at treating HIV
A bimonthly injection may eventually replace daily oral medication in the treatment of HIV
